Drug shortage: Furosemide Injection (FUROSEMIDE, HYDRALAZINE HYDROCHLORIDE)
FDA lists 30 presentations as Current. Availability: Unavailable (11), Available (16). Reason: Requirements related to complying with good manufacturing practices; Other. Companies: Baxter Healthcare, Accord Healthcare Inc., Hospira, Inc., a Pfizer Company, Gland Pharma Limited, Fresenius Kabi USA, LLC….
- Published by source
- 2020-04-07
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Baxter Healthcare
- Products
- Furosemide Injection FUROSEMIDE HYDRALAZINE HYDROCHLORIDE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Estimated recovery: TBD/ NDC non-Exempt
- Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2020-04-07
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #882 | new | 2026-10-22 | 08018f758206…08ec3f | 0cc588757925…efd7d0 |
Chain head: #1076 8ad5adc30b9b…88ce20